ArriVent BioPharma, Inc. (AVBP) Q4 2024 Annual Earnings
AVBP·Reported March 3, 2025·Before market open
Diluted EPS came in at $-0.60, beat the $-0.78 consensus by $0.18.
Diluted EPS
$-0.60beat by $0.18
Consensus: $-0.78
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about ArriVent BioPharma, Inc.'s Q4 2024 earnings report.
ArriVent BioPharma, Inc. (AVBP) reported Q4 2024 earnings on March 3, 2025 before market open.
ArriVent BioPharma, Inc. reported diluted EPS of $-0.60 for Q4 2024.
EPS beat the consensus estimate of $-0.78 by $0.18.
You can read the 10-K periodic report (0001558370-25-001999) directly on SEC EDGAR. The filing index links above go to sec.gov.